Alerts will be sent to your verified email
Verify EmailHESTERBIO
Hester Biosciences
|
Themis Medicare
|
IOL Chem & Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.53 % | 3.59 % | 0.91 % |
Financials
|
|||
5 yr Average ROE
|
12.14 % | 16.7 % | 9.87 % |
5yr average Equity Multiplier
|
2.11 | 1.64 | 1.41 |
5yr Average Asset Turnover Ratio
|
0.45 | 0.69 | 1.03 |
5yr Avg Net Profit Margin
|
12.98 % | 14.74 % | 6.75 % |
Price to Book
|
5.08 | 3.08 | 1.19 |
P/E
|
49.21 | 27.46 | 20.23 |
5yr Avg Cash Conversion Cycle
|
83.43 Days | 83.02 Days | 45.42 Days |
Inventory Days
|
106.53 Days | 75.24 Days | 64.41 Days |
Days Receivable
|
94.77 Days | 154.39 Days | 83.56 Days |
Days Payable
|
142.53 Days | 149.43 Days | 94.27 Days |
5yr Average Interest Coverage Ratio
|
7.46 | 6.9 | 17.62 |
5yr Avg ROCE
|
12.53 % | 18.52 % | 13.96 % |
5yr Avg Operating Profit Margin
|
24.84 % | 19.18 % | 10.94 % |
5 yr average Debt to Equity
|
0.74 | 0.34 | 0.03 |
5yr CAGR Net Profit
|
-8.32 % | 11.92 % | -4.32 % |
5yr Average Return on Assets
|
5.95 % | 10.34 % | 6.97 % |
Shareholdings
|
|||
Promoter Holding
|
53.73 % | 67.15 % | 52.62 % |
Share Pledged by Promoters
|
0.0 | 2.43 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.03 % | 8.93 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 0.0 | 0.0 |
Hester Biosciences
|
Themis Medicare
|
IOL Chem & Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
Capex
|
Capex
|
-
|
Capex
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|